Rikke Kaae Kirk

Novo Nordisk (Denmark)

Papers

1

Total Citations

52

H-Index

1

About

Rikke Kaae Kirk is a pioneering researcher at the intersection of bioinspired engineering and gastrointestinal drug delivery. Her work focuses on developing innovative ingestible robotic devices that mimic natural biological mechanisms—most notably, cephalopod-inspired jetting systems for needle-free administration of biomacromolecule therapies. Her landmark 2024 paper on cephalopod-inspired jetting devices for gastrointestinal drug delivery, already garnering 52 citations, addresses a critical challenge in modern medicine: enabling effective delivery of large-molecule drugs without the need for traditional needles, sharps management, or specialized training. This breakthrough has significant implications for patient compliance and global healthcare accessibility. Kirk’s research elegantly combines principles from soft robotics, biomimicry, and pharmaceutical science to create devices that can navigate the complex environment of the gastrointestinal tract and deliver therapeutics with precision. Her work represents a paradigm shift in how we approach oral drug delivery, potentially transforming treatment regimens for chronic conditions requiring biologic therapies. As an emerging leader in this rapidly evolving field, Kirk continues to push the boundaries of what is possible in non-invasive drug administration.

Research Focus

Key Achievements

1
H-Index
1
Papers
52
Total Citations
52
Avg Citations/Paper
🏆 Most Cited Paper
Cephalopod-inspired jetting devices for gastrointestinal drug delivery
52 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 41
🏛 Institutions: Novo Nordisk (Denmark)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago